Literature DB >> 7762554

Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2).

R A Spritz1, K Fukai, S A Holmes, J Luande.   

Abstract

Type II oculocutaneous albinism (OCA2) is an autosomal recessive disorder in which the biosynthesis of melanin pigment is reduced in the skin, hair, and eyes. OCA2, which results from mutations of the P gene, is the most frequent type of albinism in African and African-American patients. OCA2 is especially frequent in Tanzania, where it occurs with an incidence of approximately 1/1,400. We have identified abnormalities of the P gene in each of 13 unrelated patients with OCA2 from Tanzania. One of these, a deletion of exon 7, is strongly predominant, accounting for approximately 77% of mutant alleles in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762554      PMCID: PMC1801108     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

Review 1.  Genetic disorders of pigmentation.

Authors:  R A Spritz; V J Hearing
Journal:  Adv Hum Genet       Date:  1994

2.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

3.  Albinism and skin cancer in Southern Africa.

Authors:  J G Kromberg; D Castle; E M Zwane; T Jenkins
Journal:  Clin Genet       Date:  1989-07       Impact factor: 4.438

Review 4.  Molecular genetics of oculocutaneous albinism.

Authors:  R A Spritz
Journal:  Hum Mol Genet       Date:  1994       Impact factor: 6.150

5.  Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2).

Authors:  S T Lee; R D Nicholls; R E Schnur; L C Guida; J Lu-Kuo; N B Spinner; E H Zackai; R A Spritz
Journal:  Hum Mol Genet       Date:  1994-11       Impact factor: 6.150

6.  Albinism in Nigeria. A clinical and social study.

Authors:  A N Okoro
Journal:  Br J Dermatol       Date:  1975-05       Impact factor: 9.302

7.  The Tanzanian human albino skin. Natural history.

Authors:  J Luande; C I Henschke; N Mohammed
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

8.  Identification of a melanosomal membrane protein encoded by the pink-eyed dilution (type II oculocutaneous albinism) gene.

Authors:  S Rosemblat; D Durham-Pierre; J M Gardner; Y Nakatsu; M H Brilliant; S J Orlow
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

9.  African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism.

Authors:  D Durham-Pierre; J M Gardner; Y Nakatsu; R A King; U Francke; A Ching; R Aquaron; V del Marmol; M H Brilliant
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

10.  Base substitution in an intervening sequence of a beta+-thalassemic human globin gene.

Authors:  R A Spritz; P Jagadeeswaran; P V Choudary; P A Biro; J T Elder; J K deRiel; J L Manley; M L Gefter; B G Forget; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

View more
  13 in total

1.  Oculocutaneous albinism in an isolated Tonga community in Zimbabwe.

Authors:  P M Lund; N Puri; D Durham-Pierre; R A King; M H Brilliant
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

2.  Oculocutaneous albinism type 2 (OCA2) with homozygous 2.7-kb deletion of the P gene and sickle cell disease in a Cameroonian family. Identification of a common TAG haplotype in the mutated P gene.

Authors:  Robert Aquaron; Nadem Soufir; Jean-Louis Bergé-Lefranc; Catherine Badens; Frederic Austerlitz; Bernard Grandchamp
Journal:  J Hum Genet       Date:  2007-09-01       Impact factor: 3.172

3.  Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.

Authors:  Pedro J Santiago Borrero; Yolanda Rodríguez-Pérez; Jessicca Y Renta; Natalio J Izquierdo; Laura Del Fierro; Daniel Muñoz; Norma López Molina; Sonia Ramírez; Glorivee Pagán-Mercado; Idith Ortíz; Enid Rivera-Caragol; Richard A Spritz; Carmen L Cadilla
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

4.  Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele.

Authors:  R A Spritz; T Bailin; R D Nicholls; S T Lee; S K Park; M J Mascari; M G Butler
Journal:  Am J Med Genet       Date:  1997-07-11

5.  Molecular analysis of Korean patients with oculocutaneous albinism.

Authors:  Shin Hae Park; Hyojin Chae; Yonggoo Kim; Myungshin Kim
Journal:  Jpn J Ophthalmol       Date:  2011-11-01       Impact factor: 2.447

6.  Two cases of burns in children from French Guinea with oculocutaneous albinism.

Authors:  A Valente; E Caleffi
Journal:  Ann Burns Fire Disasters       Date:  2010-09-30

Review 7.  Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.

Authors:  Muhammad Ikram Ullah
Journal:  Genes (Basel)       Date:  2022-06-16       Impact factor: 4.141

8.  Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree.

Authors:  Jason E Hawkes; Pamela B Cassidy; Prashiela Manga; Raymond E Boissy; David Goldgar; Lisa Cannon-Albright; Scott R Florell; Sancy A Leachman
Journal:  J Dermatol Sci       Date:  2012-10-13       Impact factor: 4.563

9.  Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene.

Authors:  Manfred Kayser; Fan Liu; A Cecile J W Janssens; Fernando Rivadeneira; Oscar Lao; Kate van Duijn; Mark Vermeulen; Pascal Arp; Mila M Jhamai; Wilfred F J van Ijcken; Johan T den Dunnen; Simon Heath; Diana Zelenika; Dominiek D G Despriet; Caroline C W Klaver; Johannes R Vingerling; Paulus T V M de Jong; Albert Hofman; Yurii S Aulchenko; Andre G Uitterlinden; Ben A Oostra; Cornelia M van Duijn
Journal:  Am J Hum Genet       Date:  2008-01-25       Impact factor: 11.025

10.  Biased exon/intron distribution of cryptic and de novo 3' splice sites.

Authors:  Jana Královicová; Mikkel B Christensen; Igor Vorechovský
Journal:  Nucleic Acids Res       Date:  2005-09-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.